Cellebrite DI Ltd. (NASDAQ:CLBT – Free Report) – Stock analysts at William Blair raised their Q4 2023 EPS estimates for Cellebrite DI in a research report issued to clients and investors on Tuesday, November 14th. William Blair analyst J. Ho now expects that the company will post earnings of $0.03 per share for the quarter, […]
Cellebrite DI (NASDAQ:CLBT) Releases Earnings Results, Beats Expectations By $0 08 EPS kopsource.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from kopsource.com Daily Mail and Mail on Sunday newspapers.
Needham & Company LLC reiterated their buy rating on shares of Cellebrite DI (NASDAQ:CLBT – Free Report) in a research note issued to investors on Wednesday morning, Benzinga reports. They currently have a $10.00 price objective on the stock. A number of other equities analysts also recently commented on the stock. Deutsche Bank Aktiengesellschaft boosted […]
Cellebrite DI (NASDAQ:CLBT – Free Report) had its price target lifted by Needham & Company LLC from $7.00 to $10.00 in a report released on Wednesday morning, Benzinga reports. Needham & Company LLC currently has a buy rating on the stock. Other analysts also recently issued research reports about the stock. JPMorgan Chase & Co. […]
Cellebrite DI (NASDAQ:CLBT – Free Report) had its price objective increased by JPMorgan Chase & Co. from $8.00 to $10.00 in a research report report published on Wednesday morning, Benzinga reports. The brokerage currently has an overweight rating on the stock. A number of other brokerages have also weighed in on CLBT. Craig Hallum began […]